APA (7th ed.) Citation

Deshayes, E., Piron, L., Bouvier, A., Lapuyade, B., Lermite, E., Vervueren, L., . . . Guiu, B. (2020). Study protocol of the HYPER-LIV01 trial: A multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases. BMC cancer, 20(1), 574-7. https://doi.org/10.1186/s12885-020-07065-z

Chicago Style (17th ed.) Citation

Deshayes, Emmanuel, et al. "Study Protocol of the HYPER-LIV01 Trial: A Multicenter Phase II, Prospective and Randomized Study Comparing Simultaneous Portal and Hepatic Vein Embolization to Portal Vein Embolization for Hypertrophy of the Future Liver Remnant Before Major Hepatectomy for Colo-rectal Liver Metastases." BMC Cancer 20, no. 1 (2020): 574-7. https://doi.org/10.1186/s12885-020-07065-z.

MLA (9th ed.) Citation

Deshayes, Emmanuel, et al. "Study Protocol of the HYPER-LIV01 Trial: A Multicenter Phase II, Prospective and Randomized Study Comparing Simultaneous Portal and Hepatic Vein Embolization to Portal Vein Embolization for Hypertrophy of the Future Liver Remnant Before Major Hepatectomy for Colo-rectal Liver Metastases." BMC Cancer, vol. 20, no. 1, 2020, pp. 574-7, https://doi.org/10.1186/s12885-020-07065-z.